Skip to main content

In the Community

The Importance of Targeted Testing for Alph-1 Antitrypsin Deficiency

Wednesday, June 1, 2022
7:00 pm8:00 pm
AATD is a genetic hereditary condition that predisposes a person to the development of certain diseases (such as COPD).

Join our experts in this FREE 60-minute webinar as they discuss the results of our recent national survey, as well as the importance of Alpha-1 antitrypsin deficiency (AATD) screening and testing and how you can make an impact on both the patient's and family member's journeys.

REGISTER NOW

AATD is a genetic hereditary condition that predisposes a person to the development of certain diseases (such as COPD).

Objectives:
• Understand the pathophysiology and genetics of AATD.
• Understand the consequences of AATD for individuals diagnosed with COPD.
• Review how to make a diagnosis of AATD.
• Discuss the role genetic counselling plays in an AATD for the patient and their family.

  • New Logo
    New Logo

Powered by Firespring